Загрузка...
Long-Term Follow-Up Result of Hydroxyurea Chemotherapy for Recurrent Meningiomas
OBJECTIVE: Meningiomas represent 18-20% of all intracranial tumors and have a 20-50% 10-year recurrence rate, despite aggressive surgery and irradiation. Hydroxyurea, an inhibitor of ribonucleotide reductase, is known to inhibit meningioma cells by induction of apoptosis. We report the long-term fol...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Neurosurgical Society
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3550418/ https://ncbi.nlm.nih.gov/pubmed/23346322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3340/jkns.2012.52.6.517 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|